Posts

Who Is Eligible and How Can I Learn More About Clinical Trials?

From the Lung Cancer Town Meeting in September 2016, Janet Freeman-Daily interviews a panel of lung cancer experts about who is eligible for clinical trials and how you can learn more about them. The panel includes the following experts:

  • Nisha Monhindra, MD Assistant Professor of Medicine, Hematology/Oncology Division, Feinberg School of Medicine Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • D. Ross Camidge, MD, PhD, Director Thoracic Oncology Clinical and Clinical Research Programs University of Colorado Denver
  • David D. Odell, MD, MMSc, Assistant Professor, Thoracic Surgery Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Timothy J. Kruser, MD, Assistant Professor, Radiation Oncology Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Check out the full video below to hear all of the lung cancer experts advice.

Who is Eligible and How Can I Learn More About Clinical Trials? from Patient Empowerment Network on Vimeo.

Clinical Trials: Building on What We Know and What We Can Achieve

Interview with Dr. George Simon, MD, FACP, FCCP at MD Anderson and Dr. Rebecca Suk Heist, MD, MPH at Massachusetts General Hospital Cancer Center

At the LUNGevity Live Lung Cancer Town Meeting, Andrew Schorr interviews Dr. Simon and Dr. Heist about clinical trials. Dr. Simon explains how clinical trials can give you access to tomorrow’s medicine today. For example, Bevacizumab was first introduced in a clinical trial in 1999, but did not get approved or become standard of care until 2006/2007. Next. Dr. Heist explains how the phases of clinical trials.

  • Phase 1: Testing to find the right dosage in people
  • Phase 2: Once the recommended dose is know, testing is done to find out the real response rate and real efficacy in people
  • Phase 3: Once the dose and results are known, a randomized study is done to compare it to the standard of care to see if it really is better

Watch the full video below to hear all about clinical trials from two lung cancer experts.

Clinical Trials: Building on What We Know and What We Can Achieve from Patient Empowerment Network on Vimeo.

The Bureaucracy of Clinical Trials

At a press interview with Dr. David Stewart, Head, Division of Medical Oncology, University of Ottawa, Dr Stewart laments the extreme inefficiency of the clinical trial process. Patients are dying while government is regulating. The clinical trial process is too long, too costly and too inefficient. Watch this video from The World Conference on Lung Cancer that recently took place in Denver, Colorado:

The Bureaucracy of Lung Cancer Clinical Trials from Patient Empowerment Network on Vimeo.